SAREPTA THERAPEUTICS INC (SRPT) Stock Earnings Estimates
NASDAQ:SRPT • US8036071004
16.32 USD
-0.44 (-2.63%)
At close: Mar 2, 2026
15.95 USD
-0.37 (-2.27%)
Pre-Market: 3/3/2026, 5:09:17 AM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.243B 33.26% | 1.902B 52.97% | 2.198B 15.58% | 1.74B -20.85% | 1.47B -15.52% | 1.487B 1.16% | 1.538B 3.43% | 1.496B -2.73% | 1.438B -3.88% | 1.461B 1.60% | 1.538B 5.27% | |
| EBITDA YoY % growth | -223.427M 54.80% | 255.805M 214.49% | N/A -262.31% | 389.96M 193.92% | 309.71M -20.58% | 484.19M 56.34% | 153.91M -68.21% | 104.65M -32.01% | N/A | N/A | N/A | |
| EBIT YoY % growth | -267.824M 50.05% | 218.081M 181.43% | -657.772M -401.62% | 346.77M 152.72% | 347.84M 0.31% | 151.46M -56.46% | 160.8M 6.17% | 111.4M -30.72% | 13.822M -87.59% | -5.896M -142.66% | -26.096M -342.59% | |
| Operating Margin | -21.54% | 11.47% | -29.92% | 19.93% | 23.66% | 10.19% | 10.46% | 7.45% | 0.96% | -0.40% | -1.70% | |
| EPS YoY % growth | -6.12 23.79% | 2.28 137.25% | -6.65 -391.67% | 3.02 145.42% | 2.14 -29.13% | 1.83 -14.27% | 3.50 90.55% | 3.32 -5.10% | 3.57 7.59% | 3.69 3.36% | 3.93 6.63% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 1.14 124.84% | 0.53 -72.19% | 0.71 7,236.12% | 0.62 115.83% |
| Revenue Q2Q % growth | 481.02M -35.42% | 428.52M -29.88% | 401.96M 0.65% | 419.41M -5.31% |
| EBITDA Q2Q % growth | 202.64M 169.78% | 59.184M -56.61% | 109.16M 562.33% | N/A |
| EBIT Q2Q % growth | 103.13M 134.33% | 82.035M -29.02% | 66.63M 205.97% | 81.573M 119.89% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | -3.93 -362.00% | -1.26 | -2.67 | -213.05% |
| Q3 2025 Q2Q % growth | -0.01 -102.94% | -0.83 | 0.82 | 98.80% |
| Q2 2025 Q2Q % growth | 1.89 2,600.00% | 0.77 | 1.12 | 146.84% |
| Q1 2025 Q2Q % growth | -4.60 -1,343.24% | -0.97 | -3.63 | -376.26% |
| Q4 2024 Q2Q % growth | 1.50 219.15% | 1.93 | -0.43 | -22.48% |
| Q3 2024 Q2Q % growth | 0.34 173.91% | -0.14 | 0.48 | 348.76% |
| Q2 2024 Q2Q % growth | 0.07 125.93% | 0.01 | 0.06 | 1,173.24% |
| Q1 2024 Q2Q % growth | 0.37 106.31% | -0.08 | 0.45 | 585.99% |
| Q4 2023 Q2Q % growth | 0.47 137.90% | 0.02 | 0.45 | 3,019.73% |
| Q3 2023 Q2Q % growth | -0.46 84.35% | -1.26 | 0.80 | 63.36% |
| Q2 2023 Q2Q % growth | -0.27 89.81% | -1.81 | 1.54 | 85.10% |
| Q1 2023 Q2Q % growth | -5.86 -388.33% | -1.41 | -4.45 | -315.34% |
| Q4 2022 Q2Q % growth | -1.24 12.68% | -1.37 | 0.13 | 9.79% |
| Q3 2022 Q2Q % growth | -2.94 -1,447.37% | -1.46 | -1.48 | -101.24% |
| Q2 2022 Q2Q % growth | -2.65 -15.22% | -1.20 | -1.45 | -120.48% |
| Q1 2022 Q2Q % growth | -1.20 42.86% | -1.30 | 0.10 | 7.43% |
| Q4 2021 Q2Q % growth | -1.42 40.83% | -1.15 | -0.27 | -23.12% |
| Q3 2021 Q2Q % growth | -0.19 90.16% | -1.93 | 1.74 | 90.17% |
| Q2 2021 Q2Q % growth | -2.30 -19.17% | -1.30 | -1.00 | -76.76% |
| Q1 2021 Q2Q % growth | -2.10 -813.04% | -1.78 | -0.32 | -18.05% |
| Q4 2020 Q2Q % growth | -2.40 | -1.92 | -0.48 | -25.20% |
| Q3 2020 Q2Q % growth | -1.93 | -1.75 | -0.18 | -10.52% |
| Q2 2020 Q2Q % growth | -1.93 | -1.79 | -0.14 | -7.69% |
| Q1 2020 Q2Q % growth | -0.23 | -1.91 | 1.68 | 87.98% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 442.934M -32.73% | 399.76M | 43.174M | 10.80% |
| Q3 2025 Q2Q % growth | 399.356M -14.52% | 345.48M | 53.876M | 15.59% |
| Q2 2025 Q2Q % growth | 611.091M 68.38% | 540.58M | 70.511M | 13.04% |
| Q1 2025 Q2Q % growth | 744.856M 80.15% | 697.02M | 47.836M | 6.86% |
| Q4 2024 Q2Q % growth | 658.412M 65.94% | 640.13M | 18.282M | 2.86% |
| Q3 2024 Q2Q % growth | 467.172M 40.79% | 417.48M | 49.692M | 11.90% |
| Q2 2024 Q2Q % growth | 362.931M 38.93% | 399.23M | -36.299M | -9.09% |
| Q1 2024 Q2Q % growth | 413.464M 63.10% | 385.34M | 28.124M | 7.30% |
| Q4 2023 Q2Q % growth | 396.781M 53.55% | 394.03M | 2.751M | 0.70% |
| Q3 2023 Q2Q % growth | 331.817M 44.08% | 291.04M | 40.777M | 14.01% |
| Q2 2023 Q2Q % growth | 261.238M 11.88% | 264.74M | -3.502M | -1.32% |
| Q1 2023 Q2Q % growth | 253.5M 20.26% | 246.79M | 6.71M | 2.72% |
| Q4 2022 Q2Q % growth | 258.4M 28.24% | 253.3M | 5.1M | 2.01% |
| Q3 2022 Q2Q % growth | 230.3M 21.59% | 239.21M | -8.91M | -3.72% |
| Q2 2022 Q2Q % growth | 233.5M 42.29% | 225.23M | 8.27M | 3.67% |
| Q1 2022 Q2Q % growth | 210.8M 43.50% | 210.57M | 230K | 0.11% |
| Q4 2021 Q2Q % growth | 201.5M 38.87% | 202.58M | -1.08M | -0.53% |
| Q3 2021 Q2Q % growth | 189.4M 31.62% | 176.89M | 12.51M | 7.07% |
| Q2 2021 Q2Q % growth | 164.1M 19.43% | 165.91M | -1.81M | -1.09% |
| Q1 2021 Q2Q % growth | 146.9M 29.20% | 146.2M | 700K | 0.48% |
| Q4 2020 Q2Q % growth | 145.1M | 149.22M | -4.12M | -2.76% |
| Q3 2020 Q2Q % growth | 143.9M | 140.18M | 3.72M | 2.65% |
| Q2 2020 Q2Q % growth | 137.4M | 119.47M | 17.93M | 15.01% |
| Q1 2020 Q2Q % growth | 113.7M | 121.42M | -7.72M | -6.36% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.54% | 8.98% | -1.83% | -25.86% |
| Revenue | 0.23% | 3.29% | 0.18% | 4.06% |